Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
607 Results Found
New Healthsperien report finds that 340B drug discounts are a small share of drug company revenues
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues and revenue growth.
As urged by the AHA, 8th Circuit upholds Arkansas law protecting 340B contract pharmacy arrangements
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by the Pharmaceutical Research and Manufacturers of America, ruling that the Federal Food, Drug, and Cosmetic Act does not preempt the state law.
The 340B Drug Pricing Program
The 340B Drug Pricing Program allows hospitals caring for large numbers of underserved patients to stretch scarce federal resources and provide more comprehensive care by requiring drug companies to offer discounted prices on certain outpatient drugs.
AHA files brief defending Louisiana 340B contract pharmacy law
AHA Feb. 29 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies, its latest in a string of lawsuits claiming the federal law that created the 340B program preempts the state law.
AHA 340B Advocacy Alliance - February 21, 2024
On Feb. 2, a bipartisan group of six senators released a draft bill called the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act.
Senators Release 340B Discussion Draft & RFI
On Feb. 2, a bipartisan group of six senators released a draft bill called the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act.
AHA 340B Advocacy Alliance - February 20, 2024
The AHA 340B Alliance Feb. 22 at 3 p.m. ET will host a call for AHA members about a discussion draft of legislation to provide “clarity, transparency and accountability to the 340B program.”
AHA 340B Advocacy Alliance Bulletin - February 15, 2023
Register for Feb. 22 AHA call on Senate 340B draft legislation.
New Error-Ridden 340B Study Misses the Mark
A new study published in the New England Journal of Medicine demonstrates a stunning lack of understanding of the 340B drug pr